Key result
High-sensitivity cardiac troponin T and I showed comparable NSTEMI diagnostic accuracy with hs-cTnT adjudication, while hs-cTnI was higher with hs-cTnI adjudication.
Why the study?
Clinical practice guidelines assume that cTnT and cTnI reflect identical pathophysiological processes and are equally effective in detecting myocardial injury, yet differences between them have been reported, warranting a direct comparison of hs-cTnT and hs-cTnI for the early diagnosis of acute MI.
Does high-sensitivity cardiac troponin T improve diagnostic and prognostic accuracy for acute myocardial infarction compared to high-sensitivity cardiac troponin I in patients presenting to the emergency department with acute chest pain?
Cohort (n=5,087)
Yes
Does high-sensitivity cardiac troponin T improve diagnostic and prognostic accuracy for acute myocardial infarction compared to high-sensitivity cardiac troponin I in patients presenting to the emergency department with acute chest pain?
Although hs-cTnI demonstrated slightly higher diagnostic accuracy when adjudicated with hs-cTnI and hs-cTnT showed superior 730-day prognostic accuracy for mortality, both assays performed excellently when embedded in the ESC 0/1h early triage algorithm.
Answers are grounded in this paper and cite their sources.
Supports troponin assay equivalence in NSTEMI triage; leaves open validation with hs-cTnI adjudication in diverse cohorts.
Background Clinical practice guidelines assume that both cardiac troponin (cTn) T and cTnI concentrations reflect identical pathophysiological processes and are equally effective in the detection of myocardial injury. However, there are differences between cTnT and cTnI that have been reported. Purpose The aim of this study was to directly compare the diagnostic performance of high-sensitivity cardiac troponin (hs-cTn) T versus hs-cTnI for the early diagnosis of acute myocardial infarction (MI). Methods In a prospective multicentre study, diagnostic and prognostic accuracies of hs-cTnT and I were analyzed in consecutive patients presenting to the emergency department with acute chest pain. The final diagnosis was adjudicated by two independent cardiologists using all information pertaining to the individual patient according to the fourth universal definition of MI. Adjudication of the final diagnoses was performed twice: once using serial measurements of hs-cTnT and once using hs-cTnI. Furthermore, the clinical performance of hs-cTnT/I when embedded in the European Society of Cardiology (ESC) 0/1h-algorithm was assessed. Results Among 5087 consecutive patients (median [Interquartile range, IQR] age 61 [49.0, 74.0] years, 33.2% female), 951 (18.7%) and 901 patients (17.7%) had an adjudicated final diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) when using serial measurements of hs-cTnT and hs-cTnI for adjudication, respectively. Diagnostic accuracy was very high for both hs-cTnT and hs-cTnI and comparable when using hs-cTnT for adjudication (hs-cTnT: area under the curve [AUC] 0.93 [95% CI 0.92–0.94] versus hs-cTnI AUC 0.93 [95% CI 0.92–0.94]; p=0.891). However, when using serial measurements of hs-cTnI for adjudication, diagnostic accuracy was significantly higher for hs-cTnI (AUC 0.93 [95% CI 0.92–0.94] versus AUC 0.94 [95% CI 0.94–0.95], p<0.001; Figure 1). This was confirmed in subgroup analyses including early presenter (≤3h), patients with renal failure, known coronary artery disease and elderly (≥70 years). However, both assays performed excellent with very high safety for rule-out and high accuracy for rule-in MI when embedded in the ESC 0/1h-algorithm. Prognostic accuracies for 730-day all-cause mortality and cardiovascular death were significantly higher for hs-cTnT compared to hs-cTnI (Figure 2). Conclusions While there seem to be differences between hs-cTnT and hs-cTnI in their diagnostic and prognostic performance, clinical relevance needs to be further evaluated since both assays performed excellent when embedded in their respective early triage algorithms. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): Swiss National Foundation, Swiss Heart Foundation
No takes yet. Share an insight, caveat, or question.
Koechlin et al. (2022) conducted a cohort in Suspected acute myocardial infarction (n=5,087). High-sensitivity cardiac troponin T (hs-cTnT) vs. High-sensitivity cardiac troponin I (hs-cTnI) was evaluated on Diagnostic accuracy for non-ST-segment elevation myocardial infarction (NSTEMI) (AUC 0.93 vs 0.94 (hs-cTnI adjudication); AUC 0.93 vs 0.93 (hs-cTnT adjudication), 95% CI 0.92-0.94, p=<0.001). High-sensitivity cardiac troponin T and I showed comparable NSTEMI diagnostic accuracy with hs-cTnT adjudication, while hs-cTnI was higher with hs-cTnI adjudication.
Synapse has enriched 10 related papers. Consider them for comparative context: